Valneva Austria Gmbh

Valneva Se

Mario Nebenführ

Jürgen Heindl-Wruss

Michael Weber

Jana Barbero Calzado

Robert Schlegl

Robert Schiegl

Andreas Meinke

Arnaud Leon

Andrea Fritzer

Urban Lundberg

Jürgen Wruss

Urban Lunberg

Described herein are processes for purifying infectious virus particles and uses of protamine in such processes.

Virus purification

Described herein are Zika virus vaccines and compositions and methods of producing and administering said vaccines to subjects in need thereof.

Zika virus vaccine

The present invention relates to a process for producing an immunogenic live attenuated Chikungunya virus, as well as pharmaceutical compositions comprising the same.

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3

Described herein are processes for purifying infectious Zika virus particles and uses of protamine in such processes.

Zika virus purification

Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3

Described herein are improved purification methods for Zika virus vaccines and compositions. Also described are Zika vaccines and methods of producing and administering said Zika vaccines to subjects in need thereof.

Described herein are improved purification methods for virus vaccines and compositions. Also described are Zika, Chikungunya, dengue and yellow fever vaccines and methods of producing and administering said vaccines to subjects in need thereof.

Growing community of inventors

Vienna, Austria

Mario Nebenführ